查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018242

膽紅素檢測市場規模、佔有率和趨勢分析報告：按產品、檢測方法、患者、應用、最終用途、地區和細分市場預測（2026-2033 年）

Bilirubin Testing Market Size, Share & Trends Analysis Report By Product (Test Cartridges & Strips, Dedicated Blood Bilirubin Analyzers), By Testing, By Patient (Neonates), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10個工作天內

價格

膽紅素檢測市場概述

全球膽紅素檢測市場預計在 2025 年達到 21.6 億美元，預計到 2033 年將達到 29.4 億美元，2026 年至 2033 年的複合年成長率為 4.04%。

受新生兒醫學對早期診斷工具的迫切需求以及肝臟相關疾病日益普遍的推動，市場正在經歷變革時期。

近期，我們看到即時檢測（POC​​）領域發生了重大轉變，新型微流體設備在臨床試驗中靈敏度已超過90%。這些創新主要受新生兒黃疸發病率上升（約60%的足月嬰兒受到影響）以及非酒精性脂肪肝（NAFLD）等慢性肝病在全球激增的推動。

業界領導企業採取的策略性舉措，例如在診斷檢查室引入自動化高通量分析儀，正在簡化工作流程，並將檢測結果的取得時間從數小時縮短至數分鐘。美國小兒科會 (AAP) 等機構發布的最新臨床指南進一步推動了這一發展，這些指南倡導更嚴格的篩檢方案以預防核黃疸，從而將膽紅素檢測確立為現代兒童醫學的基本標準。

2025年7月，一項試驗研究報告了一種新型基於微流體控技術的即時檢測（POC​​）膽紅素設備。該設備與標準檢查室方法具有高度相關性（R²=0.986），並且在區分具有臨床意義的膽紅素水平方面表現出較高的靈敏度（90%）和特異性（97%）。該設備採用攜帶式光電感測技術設計，旨在傳統實驗室環境之外提供準確快速的檢測，尤其適用於資源匱乏或分散環境中的新生兒黃疸篩檢和肝功能評估。儘管樣本大小較小，需要進行更廣泛的臨床研究，但這項創新技術有望促進即時診斷的普及，提高膽紅素檢測的可及性，並推動分散式診斷和新生兒診斷市場的成長。

市場上最顯著的發展之一是經皮膽紅素測量 (TcB) 和基於智慧型手機的診斷應用程式的迅速普及。傳統上，膽紅素水平的測量是透過侵入性的「足跟穿刺」採血進行的，這會給新生兒帶來極大的不適，並存在感染風險。然而，市場正在轉向非侵入性的光感測器，這種感測器可以透過皮膚提供即時測量。人工智慧 (AI) 和機器學習領域的新研究催生了一維卷積類神經網路，該網路可以透過智慧型手機拍攝嬰兒皮膚或眼睛的圖像，以接近臨床的準確度預測膽紅素水平。這項技術飛躍不僅提高了患者的舒適度，還將市場應用擴展到家庭監測和遠端醫療領域，使父母和醫療保健專業人員無需頻繁就醫即可追蹤黃疸的進展。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：膽紅素檢測市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 膽紅素檢測市場分析工具
  • 價格分析

第4章：膽紅素檢測市場：產品具體估算與趨勢分析

  • 膽紅素檢測市場：基於產品的波動分析，2025 年和 2033 年
  • 膽紅素試劑組和檢測耗材
  • 校準試劑和品管試劑
  • 測試盒和試紙
  • 血膽紅素分析儀

第5章：膽紅素檢測市場：依技術分類的估算與趨勢分析

  • 膽紅素檢測市場：檢測趨勢分析（2025 年和 2033 年）
  • 檢查室檢測
  • 即時檢測

第6章：膽紅素檢測市場：按應用分類的估算與趨勢分析

  • 膽紅素檢測市場：基於應用領域的波動分析，2025 年和 2033 年
  • 新生兒黃疸的篩檢和監測
  • 肝功能檢查（LFT）
  • 溶血性疾病/癌症的評估
  • 定期健康檢查和術前篩檢

第7章：膽紅素檢測市場：患者特定需求估算與趨勢分析

  • 膽紅素檢測市場：2025 年和 2033 年患者特定波動分析
  • 新生
  • 兒童患者
  • 成人

第8章：膽紅素檢測市場：依最終用途分類的估算與趨勢分析

  • 膽紅素檢測市場：按最終用途分類的波動分析（2025 年和 2033 年）
  • 醫院及新生兒加護病房
  • 診斷檢查室
  • 產科和新生兒科
  • 其他

第9章：膽紅素檢測市場：區域估算與趨勢分析

  • 2025 年及 2033 年膽紅素檢測市場區域佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 南非
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 2025年全球企業市場占有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Abbott
    • Beckman Coulter, Inc.
    • Siemens Healthineers AG
    • Randox Laboratories Ltd.
    • SEKISUI Diagnostics
    • Fortress Diagnostics
    • Quidel Corporation
    • Agappe Diagnostics Ltd.
    • Nova Biomedical
    • Radiometer Medical ApS
Product Code: GVR-4-68040-871-8

Bilirubin Testing Market Summary

The global bilirubin testing market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 2.94 billion by 2033, growing at a CAGR of 4.04% from 2026 to 2033. The market is experiencing a transformative phase, driven by an urgent need for early diagnostic tools in neonatal care and the rising prevalence of liver-related diseases.

Recently, there is a significant pivot toward point-of-care (POC) testing, with new microfluidic devices achieving over 90% sensitivity in clinical trials. These innovations are largely propelled by the increasing incidence of neonatal jaundice, which affects nearly 60% of full-term infants, and the global surge in chronic liver conditions such as Nonalcoholic Fatty Liver Disease (NAFLD).

Strategic moves by industry leaders, including the integration of automated high-throughput analyzers in diagnostic labs, are streamlining workflows and reducing the time-to-result from hours to minutes. This evolution is further supported by updated clinical guidelines from organizations like the American Academy of Pediatrics (AAP), which advocate for more rigorous screening protocols to prevent kernicterus, thereby cementing bilirubin testing as a non-negotiable standard in modern pediatric healthcare.

In July 2025, a pilot study reported the development of a new microfluidic-based point-of-care device for bilirubin testing that demonstrated strong correlation (R2 = 0.986) with standard laboratory methods, along with high sensitivity (90%) and specificity (97%) in classifying clinically relevant bilirubin levels. Designed with portable optoelectronic sensing technology, the device aims to provide accurate, rapid testing outside traditional laboratory settings, particularly benefiting neonatal jaundice screening and liver function assessment in decentralized or resource-limited environments. Although validated on a small sample size and requiring broader clinical studies, the innovation supports the expansion of point-of-care diagnostics, increases accessibility to bilirubin testing, and is likely to drive growth in the decentralized and neonatal diagnostics segments of the market.

One of the most significant developments in the market scope is the rapid adoption of transcutaneous bilirubinometry (TcB) and smartphone-based diagnostic applications. Traditionally, bilirubin levels were measured via invasive "heel stick" blood draws, which cause significant distress to neonates and carry risks of infection. However, the market is now shifting toward light-based, non-invasive sensors that provide instantaneous readings through the skin. Emerging research into Artificial Intelligence (AI) and machine learning has introduced 1D Convolutional Neural Networks capable of analyzing smartphone images of an infant's skin or eyes to predict bilirubin levels with near-clinical accuracy. This technological leap not only enhances patient comfort but also expands the market's reach into home-based monitoring and remote healthcare settings, allowing parents and clinicians to track jaundice levels without frequent hospital visits.

Global Bilirubin Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bilirubin testing market report based on product, technology, application, patient, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Bilirubin Reagent Kits and Assay Consumables
  • Calibrators and Quality Controls
  • Test Cartridges and Strips
  • Dedicated Blood Bilirubin Analyzers
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Laboratory-Based Testing
  • POC Testing
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Neonatal Jaundice Screening and Monitoring
  • Liver Function Testing (LFT)
  • Hemolytic Disorders Assessment
  • Routine & Pre-operative Health Screening
  • Patient Outlook (Revenue, USD Million, 2021 - 2033)
  • Neonates
  • Pediatric Patients
  • Adults
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & NICUs
  • Diagnostic Laboratories
  • Maternity and Neonatal Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Patients
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bilirubin Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing prevalence of neonatal jaundice and liver disorders
      • 3.2.1.2. Rising adoption of point-of-care and decentralized diagnostic solutions
      • 3.2.1.3. Continuous technological advancements improving accuracy and turnaround time
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. Limited reimbursement support
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
  • 3.3. Bilirubin Testing Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Pricing Analysis

Chapter 4. Bilirubin Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bilirubin Testing Market: Product Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Bilirubin Reagent Kits and Assay Consumables
    • 4.3.1. Bilirubin Reagent Kits and Assay Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Calibrators and Quality Controls
    • 4.4.1. Calibrators and Quality Controls Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Test Cartridges and Strips
    • 4.5.1. Test Cartridges and Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Dedicated Blood Bilirubin Analyzers
    • 4.6.1. Dedicated Blood Bilirubin Analyzers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Bilirubin Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bilirubin Testing Market: Testing Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Laboratories-Based Testing
    • 5.3.1. Laboratories-Based Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. POC Testing
    • 5.4.1. POC Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Bilirubin Testing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Bilirubin Testing Market: Application Movement Analysis, USD Million, 2025 & 2033
  • 6.3. Neonatal Jaundice Screening and Monitoring
    • 6.3.1. Neonatal Jaundice Screening and Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Liver Function Testing (LFT)
    • 6.4.1. Liver Function Testing (LFT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Hemolytic Disorders Assessment/Cancer
    • 6.5.1. Hemolytic Disorders Assessment/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Routine & Pre-operative Health Screening
    • 6.6.1. Routine & Pre-operative Health Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bilirubin Testing Market: Patients Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Bilirubin Testing Market: Patients Movement Analysis, USD Million, 2025 & 2033
  • 7.3. Neonates
    • 7.3.1. Neonates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Pediatric Patients
    • 7.4.1. Pediatric Patients Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Adults
    • 7.5.1. Adults Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Bilirubin Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Bilirubin Testing Market: End Use Movement Analysis, USD Million, 2025 & 2033
  • 8.3. Hospitals & NICUs
    • 8.3.1. Hospitals & NICUs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Maternity and Neonatal Clinics
    • 8.5.1. Maternity and Neonatal Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Bilirubin Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Bilirubin Testing Market Share, By Region, 2025 & 2033, USD Million
  • 9.2. North America
    • 9.2.1. North America Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2025
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Beckman Coulter, Inc.
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. Randox Laboratories Ltd.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. SEKISUI Diagnostics
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Fortress Diagnostics
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Agappe Diagnostics Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Nova Biomedical
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Radiometer Medical ApS
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Bilirubin Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 5 Global Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 7 Global Bilirubin Testing Market, By Application, 2021 - 2033 USD Million
  • Table 8 Global Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9 Global Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 10 North America Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 11 North America Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 North America Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 13 North America Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 North America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 North America Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 16 U.S. Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 U.S. Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 18 U.S. Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 U.S. Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 U.S. Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 21 Canada Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Canada Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 23 Canada Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Canada Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Canada Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 26 Mexico Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Mexico Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 28 Mexico Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Mexico Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Mexico Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 31 Europe Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 32 Europe Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 Europe Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 34 Europe Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Europe Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Europe Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 37 UK Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 UK Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 39 UK Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 40 UK Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 UK Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 42 Germany Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Germany Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 44 Germany Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Germany America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Germany Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 47 France Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 France Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 49 France Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 50 France Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 France Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 52 Spain Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 Spain Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 54 Spain Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 Spain Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Spain Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 57 Italy Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 Italy Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 59 Italy Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 Italy Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Italy Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia-Pacific Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Asia-Pacific Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 68 China Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 69 China Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 70 China Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 71 China Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72 China Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 73 Japan Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 74 Japan Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 75 Japan Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Japan Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Japan Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 78 India Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 79 India Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 80 India Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 India Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 India Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 83 South Korea Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Korea Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 85 South Korea Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Korea Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 88 Australia Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 Australia Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 90 Australia Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 91 Australia Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Australia Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 93 Latin America Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 94 Latin America Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 95 Latin America Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 96 Latin America Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 97 Latin America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 98 Latin America Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 99 Brazil Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 100 Brazil Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 101 Brazil Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 102 Brazil Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 103 Brazil Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 104 Argentina Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 105 Argentina Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 106 Argentina Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 107 Argentina Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 108 Argentina Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 109 MEA Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 110 MEA Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 111 MEA Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 112 MEA Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 113 MEA Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 114 MEA Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 115 South Africa Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 116 South Africa Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 117 South Africa Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 118 South Africa Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 119 UAE Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 120 UAE Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 121 UAE Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 122 UAE Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 123 UAE Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 124 UAE Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million) Million
  • Table 125 Saudi Arabia Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 126 Saudi Arabia Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 127 Saudi Arabia Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 128 Saudi Arabia Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 129 Saudi Arabia Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
  • Table 130 Kuwait Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
  • Table 131 Kuwait Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
  • Table 132 Kuwait Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 133 Kuwait Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 134 Kuwait Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Bilirubin Testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2025
  • Fig. 11 In vitro diagnostic market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostic market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Bilirubin testing market: Product outlook and key takeaways
  • Fig. 19 Bilirubin testing market: Products movement analysis
  • Fig. 20 Bilirubin Reagent Kits and Assay Consumables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Calibrators and Quality Controls market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Test Cartridges and Strips market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Dedicated Blood Bilirubin Analyzers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Bilirubin testing market: Technology outlook and key takeaways
  • Fig. 25 Bilirubin Testing: Technology movement analysis
  • Fig. 26 Laboratories-Based Testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 POC Testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Bilirubin testing market: Application outlook and key takeaways
  • Fig. 29 Bilirubin testing market: Application movement analysis
  • Fig. 30 Neonatal Jaundice Screening and Monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Liver Function Testing (LFT) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Hemolytic Disorders Assessment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Routine & Pre-operative Health Screening market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Bilirubin testing market: End Use outlook and key takeaways
  • Fig. 35 Bilirubin testing market: End Use movement analysis
  • Fig. 36 Hospitals & NICUs market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 37 Diagnostic Laboratories market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 38 Home care market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 39 Other market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 40 Bilirubin testing market: test location outlook and key takeaways
  • Fig. 41 IVD treatment market: Test location movement analysis
  • Fig. 42 Point-of-care market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Homecare market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Bilirubin Testing: Regional outlook and key takeaways
  • Fig. 46 Bilirubin testing market: Regional movement analysis
  • Fig. 47 North America
  • Fig. 48 North America. market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 49 U.S. key country dynamics
  • Fig. 50 U.S. market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 51 Canada key country dynamics
  • Fig. 52 Canada market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 53 Mexico key country dynamics
  • Fig. 54 Mexico market estimates and forecast, 2021 - 2033 (USD Million),
  • Fig. 55 Europe
  • Fig. 56 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 UK key country dynamics
  • Fig. 58 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Germany key country dynamics
  • Fig. 60 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 France key country dynamics
  • Fig. 64 France market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Italy key country dynamics
  • Fig. 66 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Denmark key country dynamics
  • Fig. 68 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Sweden key country dynamics
  • Fig. 70 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 Norway key country dynamics
  • Fig. 72 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Asia Pacific
  • Fig. 74 Asia Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Japan key country dynamics
  • Fig. 76 Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 China key country dynamics
  • Fig. 78 China. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 India key country dynamics
  • Fig. 80 India. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 81 South Korea key country dynamics
  • Fig. 82 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Thailand key country dynamics
  • Fig. 84 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 85 Australia key country dynamics
  • Fig. 86 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 87 Latin America
  • Fig. 88 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 89 Brazil key country dynamics
  • Fig. 90 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 93 MEA
  • Fig. 94 MEA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 95 South Africa key country dynamics
  • Fig. 96 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 97 UAE key country dynamics
  • Fig. 98 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 99 Saudi Arabia key country dynamics
  • Fig. 100 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 101 Kuwait key country dynamics
  • Fig. 102 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)